Table 1 Baseline characteristics of hematologic oncology and subgroup of HCT patients
Variables | All hematologic oncology patients (n = 401) | HCT patients (n = 145) |
|---|---|---|
Age, years, mean (SD) | 61.6 (15.3) | 53.1 (14.3) |
Male, n (%) | 254 (63.3) | 88 (60.7) |
Hematologic diagnosis | ||
 Leukemia | 157 (39.2) | 82 (56.6) |
 Lymphoma | 131 (32.7) | 35 (24.1) |
 Multiple myeloma | 60 (14.7) | 10 (6.9) |
 Other | 53 (13.2) | 18 (12.4) |
Admission source, n (%) | ||
 Home | 341 (85.0) | 123 (84.8) |
 Acute care facility transfer | 21 (5.2) | 11 (7.6) |
 Long-term care facility transfer | 31 (7.7) | 9 (6.2) |
 Other | 8 (2.0) | 2 (1.4) |
Comorbidities, n (%) | ||
 Congestive heart failure | 43 (10.7) | 6 (4.1) |
 Arrhythmia | 66 (16.5) | 28 (19.3) |
 Valvular disease | 5 (1.2) | 2 (1.4) |
 Peripheral vascular disease | 2 (0.5) | 1 (0.7) |
 Hypertension | 80 (20.0) | 23 (15.9) |
 Chronic obstructive pulmonary disease | 30 (7.5) | 8 (5.5) |
 Diabetes mellitus | 129 (32.2) | 45 (31.0) |
 Renal failure | 26 (6.5) | 4 (2.8) |
 Liver disease | 17 (4.2) | 10 (6.9) |
 Metastatic cancer | 15 (3.7) | 6 (4.1) |
Elixhauser comorbidity score, mean (SD) | 9.6 (8.2) | 7.7 (6.6) |
Emergency department visits in past year, median (IQR) | 1 (0–2) | 0 (0–1) |
Hospital admissions in the past year, median (IQR) | 1 (0–2) | 1 (0–3) |
ICU admissions in the past year, median (IQR) | 0 (0–0) | 0 (0–0) |
Limits of care, n (%) | ||
 Full care | 300 (74.8) | 126 (86.9) |
 ICU-level care, no CPR | 22 (5.5) | 4 (2.8) |
 Do not resuscitate | 56 (14.0) | 6 (4.1) |
 Other/unknown | 23 (5.7) | 9 (6.2) |